Off-label use of drug-eluting versus bare metal stents: A lesion-specific systematic review of long-term outcomes

Nirat Beohar*, Sheridan Norman Meyers, Ata Erdogan, Matthew E. Harinstein, Karen Pieper, Stephanie Gagnon, Charles J Davidson

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Objective: The purpose of this systematic review was to evaluate differences in lesion-specific outcomes with the "off-label" use of drug-eluting stents (DES) versus bare metal stents (BMS). Methods: MEDLINE, PubMed, the Cochrane databases, and other Web were searched for studies evaluating off-label use of DES and BMS with the same characteristics. Of 1,258 abstracts or manuscripts reviewed, 112 studies were included (total N = 23,438). Studies were excluded if patients received both types of stent or no stent; lesion type was unknown; lesion-specific outcomes for â6 months were unavailable; or <25 patients were enrolled. Results: Overall mortality at 6-12 months was approximately 3% for BMS and DES for off-label use. Increase in mortality was greater from 6-12 months to 2 years with BMS than with DES (3.3%-9.1%; 2.8%-4.1%); however, rates were similar at 3 years (BMS: 18.8%; DES:15.3%). Myocardial Infarction rates were similar for both types at 6-12 months (BMS: 6.5%; DES: 6.0%). Overall rates of stent thrombosis were 1.8% and 1.7% for BMS and DES, respectively. Similar or slightly lower rates of stent thrombosis were seen for most lesion types, except higher rates for small vessels for BMS (5.2%) and true bifurcation for DES (3.3%). Rates of target lesion revascularization (TLR) were 7.5% for BMS and 19.6% for DES at 6-12 months. At 2-years TLR remained lower than DES. When the combined group was compared to registry data alone, similar values were seen. Conclusions: Rates of mortality, myocardial infarction (MI), and stent thrombosis were similar in patients receiving BMS or DES, while TLR rates were lower in DES patients.

Original languageEnglish (US)
Pages (from-to)528-545
Number of pages18
JournalJournal of Interventional Cardiology
Issue number6
StatePublished - Dec 1 2010

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Off-label use of drug-eluting versus bare metal stents: A lesion-specific systematic review of long-term outcomes'. Together they form a unique fingerprint.

Cite this